EUVIMEDEUVIMED entdecken
Crossref

The evaluation of the impact of NUDT15 variants on thiopurine metabolism in Japanese children with acute lymphoblastic leukemia

Yoichi Tanaka, Rintaro Ono, Miho Ashiarai, Ayako Sakurai, Atsushi Watanabe, Taichiro Tsuchimochi, Yosuke Hosoya, Ruri Hanajiri, Takeshi Inukai, Daisuke Hasegawa

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-025-04774-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Yoichi Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Safety Science, National Institute of Health Sciences, Kanagawa, Japan. tanakayoichi@nihs.go.jp. Hauptthemen laut MEDLINE: Antimetabolites, Antineoplastic, Mercaptopurine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pyrophosphatases. Die Arbeit nennt 26 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimetabolites, AntineoplasticMercaptopurinePrecursor Cell Lymphoblastic Leukemia-LymphomaPyrophosphatasesAdolescentChildChild, PreschoolFemaleHumansInfantMaleGenotypeGuanine NucleotidesJapanTandem Mass SpectrometryEast Asian PeopleNudix Hydrolases

Stichwörter der Autor:innen

NUDT156-MercaptopurineChildhood acute lymphoblastic leukemiaDNA-incorporated thioguanine nucleotidesThioguaine nucleotidesToxicities

Substanzen

Antimetabolites, AntineoplasticGuanine NucleotidesMercaptopurineNUDT15 protein, humanPyrophosphatasesNudix Hydrolases

Autor:innen und Institutionen

  • Division of Medicinal Safety Science, National Institute of Health Sciences, Kanagawa, Japan. tanakayoichi@nihs.go.jp.
  • Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
  • Department of Pediatrics, Japanese Red Cross Narita Hospital, Chiba, Japan.
  • Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.
  • Department of Pediatrics, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • Division of Medicinal Safety Science, National Institute of Health Sciences, Kanagawa, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Tanaka, Y., Ono, R., Ashiarai, M., Sakurai, A., Watanabe, A., Tsuchimochi, T., Hosoya, Y., Hanajiri, R., Inukai, T., & Hasegawa, D. (2025). The evaluation of the impact of NUDT15 variants on thiopurine metabolism in Japanese children with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04774-9

Vancouver

Tanaka Y, Ono R, Ashiarai M, Sakurai A, Watanabe A, Tsuchimochi T, et al. The evaluation of the impact of NUDT15 variants on thiopurine metabolism in Japanese children with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-025-04774-9

BibTeX
@article{Tanaka2025,
  author = {Tanaka, Yoichi and Ono, Rintaro and Ashiarai, Miho and Sakurai, Ayako and Watanabe, Atsushi and Tsuchimochi, Taichiro and Hosoya, Yosuke and Hanajiri, Ruri and Inukai, Takeshi and Hasegawa, Daisuke},
  title = {The evaluation of the impact of NUDT15 variants on thiopurine metabolism in Japanese children with acute lymphoblastic leukemia},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-025-04774-9}
}
Kostenlos starten →